ORAL SPRAY FORMULATIONS AND METHODS FOR ADMINISTRATION OF SILDENAFIL
The present disclosure is directed to chemically-stable and pharmaceutically- acceptable sildenafil oral spray formulations for the treatment of male erectile dysfunction, wherein the oral spray formulation has a pH of about 1.5 to less than 3Ø The present disclosure is also directed to methods for...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present disclosure is directed to chemically-stable and pharmaceutically- acceptable sildenafil oral spray formulations for the treatment of male erectile dysfunction, wherein the oral spray formulation has a pH of about 1.5 to less than 3Ø The present disclosure is also directed to methods for treating male erectile dysfunction.
La présente invention concerne des formulations pour pulvérisation orale de sildenafil chimiquement stables et acceptables pharmaceutiquement, destinées au traitement d'un trouble de l'érection chez l'homme, les formulations pour pulvérisation orale présentant un pH compris entre environ 1,5 et 3,0 tout au plus. La présente invention concerne aussi des méthodes de traitement d'un trouble de l'érection chez l'homme. |
---|